Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-24 @ 11:50 PM
NCT ID: NCT06731751
Eligibility Criteria: Inclusion Criteria: * Patients of any age with the presence of spontaneous intracranial haemorrhage (parenchymal, intraventricular and / or subarachnoid haemorrhage) on intracranial imaging (and absence of a history of trauma). AND: • Admission to hospital for sICH management. This includes admission for observation, conservative or interventional management to both ward-based and critical care settings. Exclusion Criteria: * Patients who have a clear history of trauma as the primary cause of the haemorrhage and therefore are diagnosed with traumatic intracranial haemorrhage. * Patients with subdural or extradural haematomas but no clear history of trauma. * Patients with intracranial haemorrhage occurring as a complication of a procedure or intervention (e.g. post-operative haematoma) or iatrogenic (e.g. after thrombolysis for ischaemic stroke). * Patients who undergo elective (planned admission to hospital) or semi-elective (where a patient was initially admitted to hospital, then discharged from hospital and re-admitted for surgery) procedures. * Patients re-admitted to hospital within 30 days of the initial admission with sICH (including those re-admitted for acute management of sICH-related complications). * Patient presenting to the emergency department (ED) but discharged home from the ED immediately without a period of observation or admission to a ward.
Healthy Volunteers: False
Sex: ALL
Study: NCT06731751
Study Brief:
Protocol Section: NCT06731751